Analysis | Metabolite Name | Measured Value | Units | Recovery | Gender | Treatment |
---|---|---|---|---|---|---|
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00100487 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00115135 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00115798 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00137302 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00147135 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00167011 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00173553 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00295813 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00300129 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00304637 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00332882 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00399531 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00402981 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00564566 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0058952 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00594443 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00701494 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00747496 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.00768328 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01030558 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01090266 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01111997 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01204014 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01205375 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01238278 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01360017 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01383175 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01503627 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0177615 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.01930218 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.02019607 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.02051993 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.02290151 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.02817749 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.03007612 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.03200215 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0331246 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0348746 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.03823868 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.04060514 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.04159796 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.04202663 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0441756 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.04745401 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.04924237 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0530834 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.05431661 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.05725035 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.05769064 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.05851626 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.05945686 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0617197 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.06201696 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.06364468 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.06692052 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.0671538 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.07306076 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.08023307 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.08136443 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.08184151 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.08843595 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.09918665 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.09976999 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.10948956 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.11245759 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.11693944 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.12361087 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.13742925 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.1587534 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.21889265 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.24088763 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.2558806 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.26017379 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.2625479 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.27795662 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.28440901 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.28501643 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.37479494 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.45945386 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.53018266 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.54385878 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.66778757 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.78603684 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.79755026 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 0.82671044 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 1.12861611 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 1.14267871 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 1.67797882 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 1.88653822 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 2.01135188 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 2.73356854 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 2.81862875 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 2.91127063 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 3.2547305 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 3.60444527 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 3.6609629 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 4.12395882 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 4.92221794 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 5.78570346 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 6.0472177 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 6.17763281 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 8.42637534 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 8.47702088 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 9.26515109 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 9.70925623 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 9.78837356 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 10.7859907 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 13.1089907 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 13.9070809 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 14.0356938 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 14.0734462 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 15.6849638 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 15.9525161 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 16.4338463 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Taurochenodeoxycholic acid | 17.1971903 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 17.3645426 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 17.85621 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 24.3849209 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 24.7873042 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 25.2630991 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 25.7133924 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 26.6808634 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 27.8986806 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 31.5528409 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 31.8226445 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 35.0511282 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 58.5565552 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 59.9482461 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 67.2323472 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 81.7472796 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 96.7569888 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Taurochenodeoxycholic acid | 107.335846 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 110.760997 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Taurochenodeoxycholic acid | 121.742912 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Taurochenodeoxycholic acid | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |